¼¿ï¾Æ»êº´¿ø 7th AP VALVES 2018 : 2018-08-10±³À°ÀÏÀÚ : 2018-08-10
±³À°Àå¼Ò : ¼¿ï ±×·£µå ¿öÄ¿Èú ÁöÇÏ 2Ãþ ºñ½ºÅ¸È¦
±³À°ÁÖÁ¦ :
7th AP VALVES 2018 ÁÖÃÖ±â°ü : ¼¿ï¾Æ»êº´¿ø
´ã´çÀÚ : ±èÇöÁ¤
¿¬¶ôó : 02-3010-7255
À̸ÞÀÏ :
bellakim@summitmd.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 9 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 07:30~07:40 Successful Mitral Valve-in-Valve Using TAVR THV in a Patient with Severe MR Due to Bioprosthetic Valve Failure Hyungdon Kook(Korea University Anam Hospital, Korea (Republic of))
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 07:40~07:50 Coronary Obstruction After TAVR Vincent Luk(Queen Elizabeth Hospital, Hong Kong, China)
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 07:50~08:00 Stuck Balloon of Edwards Sapien 3 Valve in Thoracic Aorta Nishant Gangil(Barts Heart Center, United Kingdom)
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 08:00~08:10 Cardiac Rupture After TAVR Edgar Lik-Wui Tay(National University Heart Centre, Singapore)
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 08:10~08:20 Embolization After TAVR Mao-Shin Lin(National Taiwan University Hospital, Taiwan)
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 08:20~08:30 Case Owen Christopher Raffel(Prince Charles Hospital, Australia)
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 08:30~09:55 Asan Medical Center, Seoul, Korea: Case #1, #2 Seung-Jung Park(Asan Medical Center, Korea (Republic of))
±âŸ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 09:55~10:00 Opening Remark Seung-Jung Park(Asan Medical Center, Korea (Republic of))
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 10:00~10:10 Conscious Sedation or General Anesthesia for TAVR: When Should We Consider General Anesthesia? In-Cheol Choi(Asan Medical Center, Korea (Republic of))
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 10:10~10:20 Mainstream of TAVR: Minimalist Approach Duk-Woo Park(Asan Medical Center, Korea (Republic of))
Åä·Ð 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 10:20~10:30 Discussion Between Panels and Audiences Tai-Leung Daniel Chan(Queen Mary¡¯s Hospital, Hong Kong(China))
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 10:30~12:00 Asan Medical Center, Seoul, Korea: Case #3, #4 Myeong-Ki Hong(Severance Hospital, Korea(Republic of))
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 12:00~12:10 CT Algorithm to Avoid Permanent Pacemaker and Para-Valvular Leakage Do-Yoon Kang(Asan Medical Center, Korea (Republic of))
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 12:10~12:20 Sapien 3 or Evolut R: Different Indications? Alan C. Yeung(Stanford University School of Medicine, USA)
Åä·Ð 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 12:20~12:30 Panel Discussion with Q & A Seung-Ho Hur(Keimyung University Dongsan Medical Center, Korea(Republic of))
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 12:30~12:40 Management of Asymptomatic Severe AS Duk-Hyun Kang(Asan Medical Center, Korea (Republic of))
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 12:40~12:50 Low Gradient AS: How to Identify and Manage? Yong-Jin Kim(Seoul National University Hospital, Korea (Republic of))
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 12:50~13:00 TAVR in Low Risk Patients Alan C. Yeung(Stanford University School of Medicine, USA)
Åä·Ð 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 13:00~13:10 Panel Discussion with Q & A Jung-Min Ahn(Asan Medical Center, Korea (Republic of))
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 13:10~13:20 TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations Jung-Min Ahn(Asan Medical Center, Korea (Republic of))
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 13:20~13:30 Optimal Antithrombotic Therapy and Ongoing Clinical Trials Duk-Woo Park(Asan Medical Center, Korea (Republic of))
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 13:30~13:40 MV and TV Intervention: Current Status and Future Perspectives Horst Sievert(CardioVascular Center Frankfurt CVC, Germany)
Åä·Ð 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 13:40~13:50 Panel Discussion with Q & A David J. Cohen(Saint Luke's Mid America Heart Institute, USA)
ÈÞ½Ä 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 13:50~14:00 ()
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 14:00~15:30 Cheng Hsin General Hospital, Taiwan: Case #1, #2 Jeng Wei(Cheng Hsin General Hospital, Taiwan)
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 15:30~15:40 Patient and Device Selection for ViV TAVR: The Good, the Bad, and the Ugly Horst Sievert(CardioVascular Center Frankfurt CVC, Germany)
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 15:40~15:50 ViV TAVR: The Role of Bioprosthetic Valve Fracture David J. Cohen(Saint Luke's Mid America Heart Institute, USA)
Åä·Ð 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 15:50~16:00 Panel Discussion with Q & A Ying-Hwa Chen(Taipei Veterans General Hospital, Taiwan)
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 16:00~17:30 The Catholic University of Korea, Seoul St. Mary''''s Hospital, Seoul, Korea: Case #1, #2 Ki-Bae Seung(The Catholic University of Korea, Seoul St. Mary¡¯s Hospital, Korea(Republic of))